https://www.selleckchem.com/pr....oducts/10-dab-10-dea
The present work can provide a valuable reference to policymakers, practitioners, and others.In this editorial piece, we first introduce the theme and objectives of the special issue on new technologies in operations and supply chains as well as their implications for sustainability. The papers comprising the special issue are then summarized, and major findings are briefly presented. Based on our observations on the submissions and the research gaps yet to be addressed, we attempt to offer our views on the directions

https://www.selleckchem.com/pr....oducts/Fasudil-HCl(H
which tended to improve by 8.6 (9.7) and 13.9 (15., respectively, at 12-months. MOS-Sleep and EQ-5D remained steady during the study, except pain/discomfort and anxiety/depression which went from 58.7% and 49.6% to 29.6% and 26.9%, respectively. At baseline, HADS showed a mean (SD) anxiety of 8.7 (4.5) and depression 5.1 (4.4), decreasing to 7.0 (4.3) and 4.7 (4.3), respectively, at 12-months. Although most CU patients are treated with NS-H1AH, disease activity is still important, negatively affecting patients' QoL, wo